Business Context and Reporting Period
This Form 8-K is a current report filed by Ginkgo Bioworks Holdings, Inc. on July 30, 2026. The filing serves as a Regulation FD disclosure to announce an upcoming investor presentation regarding the Company's business performance for the second quarter ended June 30, 2026.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement and does not contain the financial results themselves.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The report solely notifies stakeholders of the scheduled release of Q2 2026 results.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will host a presentation and Q&A session on Wednesday, August 5, 2026, at 4:30 p.m. ET.
- Access: Details and a webcast link will be available on the investor relations website. A replay will follow the session.
- Investor Engagement: Shareholders may submit questions in advance via X (using hashtag #GinkgoResults) or by emailing investors@ginkgobioworks.com.
- Communication Channels: The Company utilizes SEC filings, its website, social media (X, Instagram, Threads, LinkedIn), and its blog to disseminate material information.
Investor Verification Checklist
- Verify the date and time of the Q2 2026 earnings presentation (August 5, 2026, 4:30 p.m. ET).
- Confirm the availability of the webcast link on the official investor relations website prior to the event.
- Monitor the Company's social media channels and news site for the release of the actual financial results and any accompanying press releases.
- Note that this 8-K filing contains no financial data; the actual metrics will be disclosed during the upcoming presentation or in a subsequent filing.